ViVE 2026 Declares the Pilot Phase Over — 7,000 Attendees, 1,000+ FDA AI Clearances, and the Shadow AI Problem Nobody Wants to Discuss
ViVE 2026 drew 7,000+ attendees to Nashville with a clear consensus: healthcare AI has exited the pilot phase. The FDA has now cleared over 1,000 AI/ML-enabled medical devices. The healthcare AI market is projected at $45.2 billion. Ambient AI documentation tools show 25-41% clinician time savings. But the conference's most urgent theme was shadow AI — clinicians using consumer AI tools for clinical decisions without institutional oversight.

